Pfizer has lost over 9% since our call on February 16th. In today’s monthly we will traditionally evaluate the stock from multiple angles: the candles and candle formations, the technical indicators and the events, and the Elliott Wave and Fibonacci theories. This report can be fully viewed by the subscribers of the Stock Library package. […]
Pfizer has lost over 6% since our call in the middle of February and registered a few important signals that we discuss in this update. In this update we will also focus on the candles and the perspectives for the monthly closure. This report can be fully viewed by the subscribers of the Stock Library […]
Pfizer has been down over 5% since our call in the middle of February. The stock closed the quarter, the month, and the week with several straightforward signals which are likely to define the path for the stock for several quarters, possibly years. This monthly update focuses on the registered and perspective technical signals, and […]
Pfizer has been down more than 8% since our call almost a month ago. All targets remain intact.